Advertisement

Gastritis, Esophagitis, and Peptic Ulcer Disease

  • Alan M. Adelman
  • James P. Richardson

Abstract

Gastritis, esophagitis, and peptic ulcer disease present commonly with epigastric pain, or dyspepsia. Dyspepsia refers to upper abdominal pain or discomfort and is often associated with fullness, belching, bloating, heartburn, food intolerance, nausea, or vomiting. Dyspepsia is a common problem. Despite discoveries about the cause and treatment of peptic ulcer disease, dyspepsia remains a challenging problem to evaluate and treat.

Keywords

Gastric Cancer Gastric Ulcer Hiatal Hernia Peptic Ulcer Disease Esophageal Varix 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Lydeard S, Jones R. Factors affecting the decision to consult with dyspepsia: comparison of consulters and non-consulters. J R Coll Gen Pract 1989;39:495–8.PubMedGoogle Scholar
  2. 2.
    Johnsen R, Bernersen B, Straume B, Forde OH, Bostad L, Burhol PG. Prevalences of endoscopic and histological findings in subjects with and without dyspepsia. BMJ 1991;302: 749–52.PubMedCrossRefGoogle Scholar
  3. 3.
    Health and Public Policy Committee, American College of Physicians. Endoscopy in the evaluation of dyspepsia. Ann Intern Med 1985;102:266–9.CrossRefGoogle Scholar
  4. 4.
    Fendrick AM, Chernew ME, Hirth RA, Bloom BS. Alternative management strategies for patients with suspected peptic ulcer disease. Ann Intern Med 1995;123:260–8.PubMedCrossRefGoogle Scholar
  5. 5.
    Silverstein MD, Petterson T, Talley NJ. Initial endoscopy or empirical therapy with or without testing for Helicobacter pylori for dyspepsia: a decision analysis. Gastroenterology 1996;110:72–83.PubMedCrossRefGoogle Scholar
  6. 6.
    Bytzer P, Hansen JO, deMuckadell OB. Empirical H2-blocker therapy or prompt endoscopy in management of dyspepsia. Lancet 1994;343:811–16.PubMedCrossRefGoogle Scholar
  7. 7.
    Fraser AG, Ali MR, McCullough S, Yeates NJ, Haystead A. Diagnostic tests for Helicobacter pylori: can they help select patients for endoscopy? NZ Med J 1996;109:95–8.Google Scholar
  8. 8.
    Mendall MA, Jazrawi RP, Marrero JM, et al. Serology for Helicobacter pylori compared with symptom questionnaires in screening before direct access endoscopy. Gut 1995;36:330–3.PubMedCrossRefGoogle Scholar
  9. 9.
    Altorki NK, Skinner DB. Pathophysiology of gastroesophageal reflux. Am J Med 1989;86:685–9.PubMedCrossRefGoogle Scholar
  10. 10.
    Klinkenber-Knol EC, Festen HP, Meuwissen SG. Pharmacological management of gastro-oeshageal reflux disease. Drugs 1995;49:695–710.CrossRefGoogle Scholar
  11. 11.
    Cisapride for nocturnal heartburn. Med Lett 1994;36:11–13.Google Scholar
  12. 12.
    Robinson M. Prokinetic therapy for gastroesophageal reflux disease. Am Fam Physician 1995;52:957–66.PubMedGoogle Scholar
  13. 13.
    Roberts PJ, Cuschieri A. Laparoscopic and thorascopic antireflux surgery. Ann Chir Gynaecol 1995;84:130–7.PubMedGoogle Scholar
  14. 14.
    Richter JE. Surgery for reflux disease: reflections of a gastro-enterologist. N Engl J Med 1992;326:825–6.PubMedCrossRefGoogle Scholar
  15. 15.
    Spechler SJ, Department of Veterans Affairs Gastroesophageal Reflux Disease Study Group. Comparison of medical and surgical therapy for complicated gastroesophageal reflux disease in veterans. N Engl J Med 1992;326:786–92.CrossRefGoogle Scholar
  16. 16.
    NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. NIH consensus development panel on Helicobacter pylori in peptic ulcer disease. JAMA 1994;272: 65–9.CrossRefGoogle Scholar
  17. 17.
    McGuigan JE. Peptic ulcer and gastritis. In: Isselbacher KJ, Braunwald E, Wilson JD, Martin JB, Fauci AS, Kasper DL, editors. Harrison’s principles of internal medicine. 13th ed. New York: McGraw-Hill, 1994:1363–82.Google Scholar
  18. 18.
    Soil AH, for the Practice Parameters Committee of the American College of Gastroenterology. Medical treatment of peptic ulcer disease: practice guidelines. JAMA 1996;275:622–9.CrossRefGoogle Scholar
  19. 19.
    Hixson LJ, Kelley CL, Jones WN, Tuohy CD. Current trends in the pharmacotherapy for peptic ulcer disease. Arch Intern Med 1992;152:726–32.PubMedCrossRefGoogle Scholar
  20. 20.
    Feldman M, Burton ME. Histamine2-receptor antagonists: standard therapy for acid-peptic diseases. N Engl J Med 1990;323:1672–80.PubMedCrossRefGoogle Scholar
  21. 21.
    Poynard T, Cales P, Pasta L, et al. Beta-adrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices: an analysis of data and prognostic factors in 589 patients from four randomized clinical trials. N Engl J Med 1991;324:1532–8.PubMedCrossRefGoogle Scholar
  22. 22.
    Angélico M, Carli C, Piat C, et al. Isosorbide-5-mononitrate versus propranolol in the prevention of first bleeding in cirrhosis. Gastroenterology 1993;104:1460–5.PubMedGoogle Scholar
  23. 23.
    Mayer RJ. Neoplasms of the esophagus and stomach. In: Isselbacher KJ, Braunwald E, Wilson JD, Martin JB, Fauci AS, Kasper DL, editors. Harrison’s principles of internal medicine. 13th ed. New York: McGraw-Hill, 1994:1382–6.Google Scholar

Copyright information

© Springer Science+Business Media New York 1998

Authors and Affiliations

  • Alan M. Adelman
  • James P. Richardson

There are no affiliations available

Personalised recommendations